WTO/WHO – PRICING
June 1st, 2001
BY KEITH NUTHALLTHE PHARMACEUTICAL industry has been urged to embrace differential pricing policies in the developed and developing worlds, as a means of earning enough money to cover research costs, (in richer countries), whilst keeping drugs affordable in poorer countries. A joint World Health Organisation and World Trade Organisation workshop staged in Norway heard speeches urging companies to allow market forces to determine differential prices, to negotiate discounts with purchasers, (including bulk sales), to forge licences between patent owners and generic ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.